Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 04, 2013 07:00 ET | Source: Stem Cell Therapeutics Corp.

Stem Cell Therapeutics' Clinical Advisor and Collaborator Receives Prestigious National Award

TORONTO, ONTARIO--(Marketwired - June 4, 2013) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS) (OTCQX:SCTPF), a biopharmaceutical company developing cancer stem...
May 16, 2013 07:30 ET | Source: Stem Cell Therapeutics Corp.

Stem Cell Therapeutics to Begin Trading on the U.S. OTCQX Marketplace

TORONTO, ONTARIO--(Marketwired - May 16, 2013) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS), a biopharmaceutical company developing cancer stem cell-related technologies, today...
May 16, 2013 07:00 ET | Source: Stem Cell Therapeutics Corp.

Stem Cell Therapeutics Announces Completion of Dosing in Phase I Study of TTI-1612 in Patients With Interstitial Cystitis/Bladder Pain Syndrome

TORONTO, ONTARIO--(Marketwired - May 16, 2013) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS), a biopharmaceutical company developing cancer stem cell-related technologies, today...
April 17, 2013 07:00 ET | Source: Stem Cell Therapeutics Corp.

Stem Cell Therapeutics Licenses Exclusive Rights to Clinical Cancer Stem Cell Program

TORONTO, ONTARIO--(Marketwired - April 17, 2013) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS), a biopharmaceutical company developing cancer stem cell-related technologies, today...
April 09, 2013 18:32 ET | Source: Stem Cell Therapeutics Corp.

Stem Cell Therapeutics Completes Trillium Merger and Issues Stock Options

TORONTO, ONTARIO--(Marketwired - April 9, 2013) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS) ("SCT"), a life sciences company developing stem cell-related technologies, today...
March 28, 2013 07:00 ET | Source: Stem Cell Therapeutics Corp.

Stem Cell Therapeutics Provides Corporate Update on Acquisitions and Financing

TORONTO, ONTARIO--(Marketwire - March 28, 2013) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS) ("SCT"), a life sciences company developing stem cell-related technologies, today...
March 15, 2013 09:52 ET | Source: Stem Cell Therapeutics Corp.

Stem Cell Therapeutics Closes $3.1 Million Financing

TORONTO, ONTARIO--(Marketwire - March 15, 2013) - NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S.NEWSWIRE SERVICES Stem Cell Therapeutics Corp....
March 12, 2013 09:30 ET | Source: Stem Cell Therapeutics Corp.

Stem Cell Therapeutics Announces Filing of Prospectus Supplement for Proceeds Up to $3.5 Million of Units

TORONTO, ONTARIO--(Marketwire - March 12, 2013) - NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES Stem Cell Therapeutics Corp....
March 07, 2013 17:30 ET | Source: Stem Cell Therapeutics Corp.

Stem Cell Therapeutics Announces Offering of Up to $3.5 Million of Units

TORONTO, ONTARIO--(Marketwire - March 7, 2013) - NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S.NEWSWIRE SERVICES Stem Cell Therapeutics Corp. (TSX...
February 20, 2013 07:00 ET | Source: Stem Cell Therapeutics Corp.

REPEAT: Stem Cell Therapeutics Announces Joint-Venture Agreement With Reneu Inc. and Nexgen Medical Systems, Inc

TORONTO, ONTARIO--(Marketwire - Feb. 20, 2013) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS) ("SCT" or the "Corporation") a life sciences company developing stem cell-related...